SINOPHARM VACCINE
- December 10, 2020
- Posted by: OptimizeIAS Team
- Category: DPN Topics
No Comments
Subject: Science & tech
Context :The United Arab Emirates on Wednesday officially registered the coronavirus vaccine produced by Chinese drug giant Sinopharm, saying it was 86% effective according to analysis of third-phase trials.
Concept :
- The vaccine has been undergoing third-phase trials in the Emirates since July, and it was approved for emergency use for healthcare workers in September.
- The announcement is a significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.
- China has four vaccine products in the final stages of development, three of which — including Sinopharm — use an inactivated form of the novel coronavirus to boost immunity.
- This means they only need to be refrigerated and can be easily distributed compared to jabs developed by rivals Pfizer and BioNTech or Moderna, which have reported efficacy of 95% and 94% respectively but need to be transported at minus 70 to 20 degrees Celsius.